期刊文献+

非甾体抗炎药的不良反应 被引量:24

下载PDF
导出
摘要 非甾体抗炎药(NSAIDs)应用于临床已有100多年的历史,具有抗炎、镇痛效果,广泛应用于风湿性疾病、类风湿性疾病、炎性疾病、疼痛、软组织和运动损伤、痛经及发热的治疗,近年经过研究逐步用于心血管疾病及肿瘤的预防。目前,NSAIDs是全球处方量最大的药物之一,但使用NSAIDs的患者中约1/3发生药物相关不良反应,10%患者需停药。NSAIDs的使用也增加了患者住院和死亡风险。NSAIDs常见的不良反应包括胃肠道、肾脏、肝脏、心血管毒性和过敏反应等。
出处 《中国药师》 CAS 2006年第10期959-960,共2页 China Pharmacist
  • 相关文献

参考文献30

  • 1佘庆生.非甾体抗炎药的近况[J].上海医药,2005,26(6):263-265. 被引量:16
  • 2杨藻宸.药理学和药物治疗学[M].北京:人民卫生出版社,2000.1505.
  • 3姚中强,于孟学,韩淑玲.非甾体抗炎药[J].北京医学,2005,27(5):295-300. 被引量:37
  • 4Silverstein FE,Faich G,Goldstein JL,et al.Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis-The CLASS study:a randomized controlled trial.Celecoxib Longterm Arthritis Safety Study[J].JAMA,2002,84(10):1247-1255
  • 5Bombardier C,Laine L,Reicin A,et al.Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis[J].N Engl J Med,2000,343:1520-1528
  • 6Champion GD,Feng PH,Azuma T,et al.NSAIDs-induced gastrointestinal damage[J].Drugs,1997,53(1):6-19
  • 7McCarthy DM.Comparative toxicity of non-steroidal anti-inflammatory drugs[J].AM J Med,1999,107(6A):37S-47S.46S-47S
  • 8王国平,郑旭.非甾体抗炎药相关性上消化道出血的临床特点[J].海峡药学,2004,16(5):106-108. 被引量:13
  • 9Tanaka A,Hase S,Miyazawa T,et al.Up-regulation of cyelocxygenase-2 by inhibition of cyclooxygenase-1:a key to nonsteroidal anti-inflammatory drug-induced intestinal damage[J].J Pharmacol Exp Ther,2002,33 (3):754-761
  • 10张炳勇,白鸽,张惠丽,杨玉秀.非甾体抗炎药相关性上消化道出血临床特点[J].医药论坛杂志,2005,26(13):34-35. 被引量:16

二级参考文献145

  • 1李中芬.非甾体抗炎药尼美舒利的不良反应[J].药物不良反应杂志,2002,(5):329-329.
  • 2Andrade RJ, Lucena MI. Fernandez MC, Gonzalez M. Fatal hepatitis associated with nimesulide. J Hepatol 2000;32:174.
  • 3Romero-Gomez M, Nevado Santos M, Otero Fernandez MA,Fovelo MJ,Suarez-Garcia E, Castro Fernandez M. Acute cholestatic hepatitis induced by nimesulide. Liver 1999;19:164-165.
  • 4Boelsterli UA. Mechanisms of NSAID-induced hepatotoxicity:focus on nimesulide. Drug Saf 2002;25:633-648.
  • 5Mingatto FE, Rodrigues T, Pigoso AA, Uyemura SA, Curti C,Santos AC. The critical role of mitochondrial energetic impairment in the toxicity of nimesulide to hepatocytes. J Pharmacol Exp Ther 2002;303:601-607.
  • 6Macia MA, Carvajal A, del Pozo JG, Vera E, del Pino A.Hepatotoxicity associated with nimesulide: data from the Spanish Pharmacovigilance system. Clin Pharmacol Ther 2002;72:596-597.
  • 7Van Steenbergen W, Peeters P, De Bondt J, Staessen D, Buscher H, Laporta T, Roskams T, Desmet Vo Nimesulide-induced acute hepatitis: evidence from six cases. J Hepatol 1998;29:135-141.
  • 8McCormick PA, Kennedy F, Curry. M, Traynor O.COX 2 inhibitor and fulminant hepatic failure. The Lancet 1999;3.53:40-41.
  • 9Merlani G, Fox M, Oehen HP, Cathomas G, Renner EL, Fattinger K, Schneemann M, Kullak-Dblick GA. Fatal hepatoxicity secondary to nimesulide. Eur J Clin Pharmacol 2001;57:321-326.
  • 10Vane JR, Botting RM. Overview: the mechanism of action of anti-inflammatory drugs.//Vane JR, Botting RM,eds. Clinical significance and potential of selective COX-2 inhibitors [M]. London:William Harvey Press,1998:1-11.

共引文献302

同被引文献178

引证文献24

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部